Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) shares crossed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $0.77 and traded as high as $0.8850. Eagle Pharmaceuticals shares last traded at $0.8850, with a volume of 3,300 shares traded.
Eagle Pharmaceuticals Stock Performance
The stock has a market capitalization of $11.43 million, a price-to-earnings ratio of 0.75 and a beta of 0.83. The company has a 50-day moving average of $0.81 and a 200-day moving average of $0.59.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc was a specialty pharmaceutical company focused on developing and commercializing injectable and intranasal medicines, with an emphasis on products intended to improve existing therapies through differentiated formulations, dosing approaches, or delivery technologies. The company primarily served hospital, oncology, emergency medicine, and critical-care markets.
Eagle’s marketed products included Ryanodex, an injectable formulation of dantrolene sodium used to treat malignant hyperthermia; Belrapzo, a formulation of bendamustine hydrochloride used in certain blood cancers; and Pemfexy, a ready-to-dilute formulation of pemetrexed used in the treatment of certain lung cancers and mesothelioma.
Recommended Stories
- Five stocks we like better than Eagle Pharmaceuticals
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
